Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Long-Term Debt Repayments (2017 - 2025)

Historic Long-Term Debt Repayments for Editas Medicine (EDIT) over the last 4 years, with Q1 2025 value amounting to $2.9 million.

  • Editas Medicine's Long-Term Debt Repayments changed N/A to $2.9 million in Q1 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 111694.92%. This contributed to the annual value of $857000.0 for FY2018, which is 1217.28% up from last year.
  • According to the latest figures from Q1 2025, Editas Medicine's Long-Term Debt Repayments is $2.9 million.
  • Editas Medicine's Long-Term Debt Repayments' 5-year high stood at $2.9 million during Q1 2025, with a 5-year trough of $2.9 million in Q1 2025.